Agnico-Eagle Mines Ltd. (0R2J)
London Exchange · UK · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 243.26 |
|---|---|
| 52-week range | 44.84 – 347.82 |
| Return, 1 month / 3 months | −12.1% / +20.9% |
| Return, 1 year / 3 years | +6.9% / +280.0% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 261.4% |
| Worst drawdown (1 year) | -86.8% |
| Average daily value traded | 1.34M CAD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Agnico-Eagle Mines is a Canadian gold mining company based in Toronto. It operates underground and open-pit mines in Canada, Finland and Mexico, producing gold doré and concentrate. Alongside gold, its operations yield silver, zinc and copper as by-products. The company supplies precious metals to refiners and markets worldwide, and it also carries out mineral exploration and mine development at its properties.
On this site Agnico-Eagle Mines Ltd. appears as a stock on the London Exchange (UK), code 0R2J, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Agnico-Eagle Mines Ltd. (0R2J) trades on the London Exchange in UK. It last closed at CAD 243.26 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 2,627 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 6.9% and over the last three months it rose 20.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 42 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.5% | ||
| From 52-week high | -28.8% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 20.9% | ||
| 6-month return | -9.7% | ||
| 12-month return, skipping the last month | 21.6% | ||
| Stability (higher is calmer) | 2 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 261.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -86.8% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.34M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 50 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −8.1% |
|---|---|
| 1 month | −12.1% |
| 3 months | +20.9% |
| 6 months | −9.7% |
| 1 year | +6.9% |
| 3 years | +280.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 266.89 / 260.12 |
|---|---|
| Golden / death cross (60 days) | Golden, 10 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | CAD 0.6247 |
| 29 May 2026 | CAD 0.6199 |
| 27 Feb 2026 | CAD 0.6137 |
| 28 Nov 2025 | CAD 0.5576 |
| 2 Sep 2025 | CAD 0.5518 |
| 30 May 2025 | CAD 0.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.